Baseline left ventricular ejection fraction associated with symptom improvements in both children and adolescents with postural tachycardia syndrome under metoprolol therapy

Abstract. Background:. Postural tachycardia syndrome (POTS) is a common childhood disease that seriously affects the patient's physical and mental health. This study aimed to investigate whether pre-treatment baseline left ventricular ejection fraction (LVEF) and left ventricular fractional sho...

Full description

Bibliographic Details
Main Authors: Yuan-Yuan Wang, Zhen-Hui Han, Yu-Li Wang, Ying Liao, Chun-Yu Zhang, Ping Liu, Chao-Shu Tang, Jun-Bao Du, Hong-Fang Jin, Ya-Qian Huang, Ning-Ning Wang
Format: Article
Language:English
Published: Wolters Kluwer 2021-08-01
Series:Chinese Medical Journal
Online Access:http://journals.lww.com/10.1097/CM9.0000000000001698
_version_ 1818572737281523712
author Yuan-Yuan Wang
Zhen-Hui Han
Yu-Li Wang
Ying Liao
Chun-Yu Zhang
Ping Liu
Chao-Shu Tang
Jun-Bao Du
Hong-Fang Jin
Ya-Qian Huang
Ning-Ning Wang
author_facet Yuan-Yuan Wang
Zhen-Hui Han
Yu-Li Wang
Ying Liao
Chun-Yu Zhang
Ping Liu
Chao-Shu Tang
Jun-Bao Du
Hong-Fang Jin
Ya-Qian Huang
Ning-Ning Wang
author_sort Yuan-Yuan Wang
collection DOAJ
description Abstract. Background:. Postural tachycardia syndrome (POTS) is a common childhood disease that seriously affects the patient's physical and mental health. This study aimed to investigate whether pre-treatment baseline left ventricular ejection fraction (LVEF) and left ventricular fractional shortening (LVFS) values were associated with symptom improvement after metoprolol therapy for children and adolescents with POTS. Methods:. This retrospective study evaluated 51 children and adolescents with POTS who received metoprolol therapy at the Peking University First Hospital between November 2010 and July 2019. All patients had completed a standing test or basic head-up tilt test and cardiac echocardiography before treatment. Treatment response was evaluated 3 months after starting metoprolol therapy. The pre-treatment baseline LVEF and LVFS values were evaluated for correlations with decreases in the symptom score after treatment (ΔSS). Multivariable analysis was performed using factors with a P value of <0.100 in the univariate analyses and the demographic characteristics. Results:. A comparison of responders and non-responders revealed no significant differences in demographic, hemodynamic characteristics, and urine specific gravity (all P > 0.050). However, responders had significantly higher baseline LVEF (71.09% ± 4.44% vs. 67.17% ± 4.88%, t = −2.789, P = 0.008) and LVFS values (40.00 [38.00, 42.00]% vs. 36.79% ± 4.11%, Z = −2.542, P = 0.010) than the non-responders. The baseline LVEF and LVFS were positively correlated with ΔSS (r = 0.378, P = 0.006; r = 0.363, P = 0.009), respectively. Logistic regression analysis revealed that LVEF was independently associated with the response to metoprolol therapy in children and adolescents with POTS (odds ratio: 1.201, 95% confidence interval: 1.039–1.387, P = 0.013). Conclusions:. Pre-treatment baseline LVEF was associated with symptom improvement after metoprolol treatment for children and adolescents with POTS.
first_indexed 2024-12-15T00:01:37Z
format Article
id doaj.art-3aa8359616574252bb623786e0f6698f
institution Directory Open Access Journal
issn 0366-6999
2542-5641
language English
last_indexed 2024-12-15T00:01:37Z
publishDate 2021-08-01
publisher Wolters Kluwer
record_format Article
series Chinese Medical Journal
spelling doaj.art-3aa8359616574252bb623786e0f6698f2022-12-21T22:42:52ZengWolters KluwerChinese Medical Journal0366-69992542-56412021-08-01134161977198210.1097/CM9.0000000000001698202108200-00012Baseline left ventricular ejection fraction associated with symptom improvements in both children and adolescents with postural tachycardia syndrome under metoprolol therapyYuan-Yuan WangZhen-Hui HanYu-Li WangYing LiaoChun-Yu ZhangPing LiuChao-Shu TangJun-Bao DuHong-Fang JinYa-Qian HuangNing-Ning WangAbstract. Background:. Postural tachycardia syndrome (POTS) is a common childhood disease that seriously affects the patient's physical and mental health. This study aimed to investigate whether pre-treatment baseline left ventricular ejection fraction (LVEF) and left ventricular fractional shortening (LVFS) values were associated with symptom improvement after metoprolol therapy for children and adolescents with POTS. Methods:. This retrospective study evaluated 51 children and adolescents with POTS who received metoprolol therapy at the Peking University First Hospital between November 2010 and July 2019. All patients had completed a standing test or basic head-up tilt test and cardiac echocardiography before treatment. Treatment response was evaluated 3 months after starting metoprolol therapy. The pre-treatment baseline LVEF and LVFS values were evaluated for correlations with decreases in the symptom score after treatment (ΔSS). Multivariable analysis was performed using factors with a P value of <0.100 in the univariate analyses and the demographic characteristics. Results:. A comparison of responders and non-responders revealed no significant differences in demographic, hemodynamic characteristics, and urine specific gravity (all P > 0.050). However, responders had significantly higher baseline LVEF (71.09% ± 4.44% vs. 67.17% ± 4.88%, t = −2.789, P = 0.008) and LVFS values (40.00 [38.00, 42.00]% vs. 36.79% ± 4.11%, Z = −2.542, P = 0.010) than the non-responders. The baseline LVEF and LVFS were positively correlated with ΔSS (r = 0.378, P = 0.006; r = 0.363, P = 0.009), respectively. Logistic regression analysis revealed that LVEF was independently associated with the response to metoprolol therapy in children and adolescents with POTS (odds ratio: 1.201, 95% confidence interval: 1.039–1.387, P = 0.013). Conclusions:. Pre-treatment baseline LVEF was associated with symptom improvement after metoprolol treatment for children and adolescents with POTS.http://journals.lww.com/10.1097/CM9.0000000000001698
spellingShingle Yuan-Yuan Wang
Zhen-Hui Han
Yu-Li Wang
Ying Liao
Chun-Yu Zhang
Ping Liu
Chao-Shu Tang
Jun-Bao Du
Hong-Fang Jin
Ya-Qian Huang
Ning-Ning Wang
Baseline left ventricular ejection fraction associated with symptom improvements in both children and adolescents with postural tachycardia syndrome under metoprolol therapy
Chinese Medical Journal
title Baseline left ventricular ejection fraction associated with symptom improvements in both children and adolescents with postural tachycardia syndrome under metoprolol therapy
title_full Baseline left ventricular ejection fraction associated with symptom improvements in both children and adolescents with postural tachycardia syndrome under metoprolol therapy
title_fullStr Baseline left ventricular ejection fraction associated with symptom improvements in both children and adolescents with postural tachycardia syndrome under metoprolol therapy
title_full_unstemmed Baseline left ventricular ejection fraction associated with symptom improvements in both children and adolescents with postural tachycardia syndrome under metoprolol therapy
title_short Baseline left ventricular ejection fraction associated with symptom improvements in both children and adolescents with postural tachycardia syndrome under metoprolol therapy
title_sort baseline left ventricular ejection fraction associated with symptom improvements in both children and adolescents with postural tachycardia syndrome under metoprolol therapy
url http://journals.lww.com/10.1097/CM9.0000000000001698
work_keys_str_mv AT yuanyuanwang baselineleftventricularejectionfractionassociatedwithsymptomimprovementsinbothchildrenandadolescentswithposturaltachycardiasyndromeundermetoprololtherapy
AT zhenhuihan baselineleftventricularejectionfractionassociatedwithsymptomimprovementsinbothchildrenandadolescentswithposturaltachycardiasyndromeundermetoprololtherapy
AT yuliwang baselineleftventricularejectionfractionassociatedwithsymptomimprovementsinbothchildrenandadolescentswithposturaltachycardiasyndromeundermetoprololtherapy
AT yingliao baselineleftventricularejectionfractionassociatedwithsymptomimprovementsinbothchildrenandadolescentswithposturaltachycardiasyndromeundermetoprololtherapy
AT chunyuzhang baselineleftventricularejectionfractionassociatedwithsymptomimprovementsinbothchildrenandadolescentswithposturaltachycardiasyndromeundermetoprololtherapy
AT pingliu baselineleftventricularejectionfractionassociatedwithsymptomimprovementsinbothchildrenandadolescentswithposturaltachycardiasyndromeundermetoprololtherapy
AT chaoshutang baselineleftventricularejectionfractionassociatedwithsymptomimprovementsinbothchildrenandadolescentswithposturaltachycardiasyndromeundermetoprololtherapy
AT junbaodu baselineleftventricularejectionfractionassociatedwithsymptomimprovementsinbothchildrenandadolescentswithposturaltachycardiasyndromeundermetoprololtherapy
AT hongfangjin baselineleftventricularejectionfractionassociatedwithsymptomimprovementsinbothchildrenandadolescentswithposturaltachycardiasyndromeundermetoprololtherapy
AT yaqianhuang baselineleftventricularejectionfractionassociatedwithsymptomimprovementsinbothchildrenandadolescentswithposturaltachycardiasyndromeundermetoprololtherapy
AT ningningwang baselineleftventricularejectionfractionassociatedwithsymptomimprovementsinbothchildrenandadolescentswithposturaltachycardiasyndromeundermetoprololtherapy